Use of an anti-ras ribozyme to alter the malignant phenotype of a human bladder cancer cell line

Journal of Urology

Volumn 156, Issue 3, 1996, Pages 1186-1188

  Eastham, James A ^b   Ahlering, Thomas E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

genes; neoplasms; ras; RNA, catalytic

Indexed keywords

ONCOPROTEIN; RIBOZYME;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CANCER INHIBITION; CONTROLLED STUDY; ENZYME THERAPY; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; ONCOGENE RAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0029758509     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65747-1     Document Type: Article

References (14)

1. Tabin, C. U., Bradley, C. M., Bargmann, C. I., Weiberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R. I., Lowry, D. R. and Chang, E. H.: Mechanisms of activation of a human oncogene. Nature, 300: 143, 1982.
2. Marshal, C. J., Franks, L. M. and Carbonell, A. W.: Markers of neoplastic transformation in epithelial cells derived from human carcinomas. J. Natl. Cancer Inst., 58: 1743, 1977.
3. Shih, C. and Weinver, R. A.: Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell, 29: 161, 1982.
4. Capon, D. J., Chen, E. Y., Levinson, A. D., Seeburg, P. H. and Goeddel, D. V.: Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature, 302: 33, 1983.
5. Mulcahy, L. S., Smith, M. R. and Stacey, D. W.: Requirements for ras proto-oncogene and its normal homologue. Nature, 302: 33, 1983.
6. Theodorescu, D., Cornil, I. I., Fernandez, B. J. and Vieabel, R. R.: Overexpression of normal and mutated forms of H-ras induces orthotopic bladder invasion in a human transitional cell carcinoma. Proc. Natl. Acad. Sci. U.S.A., 87: 9047, 1990.
7. Cech, T. R. and Bass, B. L.: Biological catalysis of RNA. Annu. Rev. Biochem., 55: 599, 1986.
8. Scanlon, K. J., Jiao, L., Funato, T., Wang, W., Tone, T. I., Rossi, J. J. and Kashani-Sabet, M.: Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein. Proc. Natl. Acad. Sci. U.S.A., 88: 106591, 1991.
9. Kashani-Sabet, M., Funato, T., Tone, T., Jiao, L., Wang, W. I., Yoshida, E., Wu, A. M., Moreno, J. G., Traweek, T. E., Ahlering, T. E. and Scanlon, K. J.: Reversal of the malignant phenotype by an anti-ras ribozyme. Antisense Res. Dev., 2: 3, 1992.
10. Ahlering, T. E., Dubeau, L. and Jones, P. A.: A new in vivo model to study invasion and metastasis of human bladder carcinoma. Cancer Res., 47: 6660, 1987.
11. Ausubel, F. M., Brent, R., Kingston, R. E., Morore, D. D., Seidman, J. G., Smith, J. A. and Struhl, K. (eds.): Current Protocols In Molecular Biology. New York: Wiley, vol. 1, 1988.
12. Saiki, R. K., Gelfand, D. H., Stoffel, S. I., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B. and Erlich, H. A.: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239: 487, 1987.
13. Kashani-Sabet, M., Rossi, J. J., Lu, Y., Ma, J. X., Chen, J., Miyachi, H. and Scanlon, K. J.: Detection of drug resistance in human tumors by in vitro enzymatic amplification. Cancer Res., 48: 5775, 1988.
14. Tone, T., Kashani-Sabet, M., Funato, T., Shitara, J., Yoshido, E., Kashfirn, B. I., Horng, M., Fodstadt, O. and Scanlon, K. J.: Suppression of EJ cells tumorigenicty. In Vivo, 7: 471, 1993.